...
首页> 外文期刊>Archives of Toxicology >Application of a multi-layer systems toxicology framework for in vitro assessment of the biological effects of Classic Tobacco e-liquid and its corresponding aerosol using an e-cigarette device with MESH (TM) technology
【24h】

Application of a multi-layer systems toxicology framework for in vitro assessment of the biological effects of Classic Tobacco e-liquid and its corresponding aerosol using an e-cigarette device with MESH (TM) technology

机译:多层系统毒理学框架的应用,以烟草(TM)技术用电子卷烟装置对经典烟草E-液体的生物学效应的体外评估及其相应的气雾剂

获取原文
获取原文并翻译 | 示例
           

摘要

We previously proposed a systems toxicology framework for in vitro assessment of e-liquids. The framework starts with the first layer aimed at screening the potential toxicity of e-liquids, followed by the second layer aimed at investigating the toxicity-related mechanism of e-liquids, and finally, the third layer aimed at evaluating the toxicity-related mechanism of the corresponding aerosols. In this work, we applied this framework to assess the impact of the e-liquid MESH Classic Tobacco and its aerosol compared with that of cigarette smoke (CS) from the 3R4F reference cigarette. In the first layer, we evaluated the cytotoxicity profile of the MESH Classic Tobacco e-liquid (containing humectants, nicotine, and flavors) and its Base e-liquid (containing humectant and nicotine only) in comparison with total particulate matter (TPM) of 3R4F CS using primary bronchial epithelial cell cultures. In the second layer, the same culture model was used to explore changes in specific markers using high-content screening assays to identify potential toxicity-related mechanisms induced by the MESH Classic Tobacco and Base e-liquids beyond cell viability in comparison with the 3R4F CS TPM-induced effects. Finally, in the third layer, we compared the impact of exposure to the MESH Classic Tobacco or Base aerosols with 3R4F CS using human organotypic air-liquid interface buccal and small airway epithelial cultures. The results showed that the cytotoxicity of the MESH Classic Tobacco liquid was similar to the Base liquid but lower than 3R4F CS TPM at comparable nicotine concentrations. Relative to 3R4F CS exposure, MESH Classic Tobacco aerosol exposure did not cause tissue damage and elicited lower changes in the mRNA, microRNA, and protein markers. In the context of tobacco harm reduction strategy, the framework is suitable to assess the potential-reduced impact of electronic cigarette aerosol relative to CS.
机译:我们之前提出了一种系统毒理学框架,用于对E-液体进行体外评估。该框架从旨在筛选e-液体的潜在毒性的第一层开始,然后旨在研究胃肠液体的毒性相关机制的第二层,最后,旨在评估毒性相关机制的第三层相应的气溶胶。在这项工作中,我们将此框架应用于评估电子液体网格经典烟草及其气溶胶的影响与来自3R4F参考香烟的香烟烟雾(CS)相比。在第一层中,我们评估了与总颗粒物(TPM)相比使用初级支气管上皮细胞培养物3R4F CS。在第二层中,使用相同的培养模型用于探讨使用高含量筛选测定的特定标志物的变化,以鉴定与3R4F CS相比细胞活力超出细胞活力的网状经典烟草和基础E-液体诱导的潜在毒性相关机制TPM诱导的效果。最后,在第三层中,我们使用人体有机型空气 - 液体界面颊和小气道上皮培养,将暴露于网状经典烟草或基础气溶胶的影响与3R4F CS进行了比较。结果表明,网眼经典烟草液的细胞毒性与基础液体相似但在相当的尼古丁浓度下低于3R4F CS TPM。相对于3R4F CS曝光,网格经典烟草气溶胶暴露不会引起组织损伤并引发mRNA,microRNA和蛋白质标记的较低变化。在烟草损害策略的背景下,该框架适用于评估电子卷烟气溶胶相对于Cs的潜在 - 减少影响。

著录项

  • 来源
    《Archives of Toxicology》 |2019年第11期|共19页
  • 作者单位

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

    Philip Morris Prod SA Philip Morris Int R&

    D Quai Jeanrenaud 5 CH-2000 Neuchatel Switzerland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 毒物学(毒理学);
  • 关键词

    E-cigarettes; Transcriptomics; Systems toxicology; High-content screening; Airway epithelial;

    机译:电子香烟;转录组织;系统毒理学;高含量的筛选;气道上皮;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号